Create
Learn
Share

Categories of Chemotherapy Emetogenic Risk (MASCC)

rename
scapharm's version from 2016-04-12 17:37

Section

Question Answer
High risk in nearly all patients (>90%)
Moderaterisk in 30% to 90% of patients
Lowrisk in 10% to 30% of patients
Minimalfewer than 10% at risk
memorize